收费全文 | 1040456篇 |
免费 | 71608篇 |
国内免费 | 3005篇 |
耳鼻咽喉 | 13761篇 |
儿科学 | 32207篇 |
妇产科学 | 28712篇 |
基础医学 | 145415篇 |
口腔科学 | 27967篇 |
临床医学 | 88518篇 |
内科学 | 213149篇 |
皮肤病学 | 21705篇 |
神经病学 | 85214篇 |
特种医学 | 42036篇 |
外国民族医学 | 342篇 |
外科学 | 162857篇 |
综合类 | 20788篇 |
现状与发展 | 2篇 |
一般理论 | 381篇 |
预防医学 | 74930篇 |
眼科学 | 23104篇 |
药学 | 73606篇 |
2篇 | |
中国医学 | 2036篇 |
肿瘤学 | 58337篇 |
2021年 | 8446篇 |
2019年 | 8979篇 |
2018年 | 12203篇 |
2017年 | 9611篇 |
2016年 | 10474篇 |
2015年 | 11944篇 |
2014年 | 16973篇 |
2013年 | 25498篇 |
2012年 | 35289篇 |
2011年 | 37519篇 |
2010年 | 22457篇 |
2009年 | 21375篇 |
2008年 | 35539篇 |
2007年 | 37666篇 |
2006年 | 37398篇 |
2005年 | 37237篇 |
2004年 | 35493篇 |
2003年 | 34186篇 |
2002年 | 33227篇 |
2001年 | 42725篇 |
2000年 | 43577篇 |
1999年 | 37730篇 |
1998年 | 11901篇 |
1997年 | 10649篇 |
1996年 | 10374篇 |
1995年 | 9634篇 |
1994年 | 9125篇 |
1993年 | 8608篇 |
1992年 | 28898篇 |
1991年 | 27696篇 |
1990年 | 26963篇 |
1989年 | 25876篇 |
1988年 | 24061篇 |
1987年 | 23684篇 |
1986年 | 22722篇 |
1985年 | 21639篇 |
1984年 | 16385篇 |
1983年 | 13996篇 |
1982年 | 8778篇 |
1979年 | 14912篇 |
1978年 | 10546篇 |
1977年 | 8999篇 |
1976年 | 8457篇 |
1975年 | 9225篇 |
1974年 | 10923篇 |
1973年 | 10384篇 |
1972年 | 9830篇 |
1971年 | 9042篇 |
1970年 | 8718篇 |
1969年 | 8107篇 |
Background
Obesity is a risk factor for acetabular component malposition when total hip arthroplasty is performed with manual techniques. The utility of imageless navigation in obese patients remains unknown. This study compared the accuracy and precision of imageless navigation for component orientation between obese and nonobese patients.Methods
A total of 459 total hip arthroplasties performed for osteoarthritis using imageless navigation were reviewed from a single surgeon’s institutional review board–approved database. Einzel-Bild-Roentgen Analyse determined component orientation on 6-week postoperative anteroposterior radiographs. Mean orientation error (accuracy) and precision were compared between obese (body mass index ≥ 30 kg/m2) and nonobese patients. Regression analysis evaluated the influence of obesity on component position.Results
The difference in mean inclination and anteversion between obese and nonobese groups was 1.1° (43.0° ± 3.5°; range, 35.8°-57.8° vs 41.9° ± 4.4°; range, 33.0°-57.1° and 24.9° ± 6.3°; range, 14.2°-44.3° vs 23.8° ± 6.6°; range, 7.0°-38.6°, respectively). Inclination precision was better for nonobese patients. No difference in inclination accuracy or anteversion accuracy or precision was detected between groups. And 83% of components were placed within the target range. There was no relationship between obesity (dichotomized) and component placement outside the target ranges for inclination, anteversion, or both. As a continuous variable, increased body mass index correlated with higher odds of inclination outside the target zone (odds ratio, 1.06; P = .001).Conclusion
Using imageless navigation, inclination orientation was less precise for obese patients, but the observed difference is likely not clinically relevant. Accurate superficial registration of landmarks in obese patients is achievable, and the use of imageless navigation similarly improves acetabular component positioning in obese and nonobese patients.Level of Evidence
Therapeutic Level IV. 相似文献Areas covered: This review focuses on current treatments and the future outlook for allergic rhinitis. Pharmacotherapy includes mast cell stabilizers, antihistamines, glucocorticosteroids (GCSs), leukotriene receptor antagonists, and nasal decongestants. Nasal GCSs are currently regarded as the most effective treatment and are considered first-line therapy together with non-sedating antihistamines. The new formulation MP29-02 combines the nasal GCS fluticasone propionate with azelastine in one single spray and has achieved greater improvements than those under monotherapy with modern GCSs or antihistamines. Furthermore, this review discusses allergen immunotherapy alone and in combination with modern monoclonal antibodies.
Expert opinion: Despite the variety of medications for allergic rhinitis, ranging from general symptomatic agents like GCSs or decongestants, to more specific ones like histamine receptor or leukotriene blockers, to causal therapy like immunotherapy, many patients still experience treatment failures or unsatisfactory results. The ultimate goal may be to endotype every downstream pathway separately in order to offer patients individualized, targeted therapy with specific antibodies against the respective pathway. 相似文献